The Application of 18F-FES PET in Clinical Cancer Care: A Systematic Review

CONCLUSIONS: [18F]fluoroestradiol PET is not only a convenient and accurate diagnostic imaging tool for detecting ER-expressing lesions in patients with breast and ovarian cancer but also among patients with uterine cancer. [18F]fluoroestradiol PET is a noninvasive predictive and monitoring tool for treatment response and prognosis.PMID:37482660 | DOI:10.1097/RLU.0000000000004760

Source: Clinical Genitourinary Cancer - July 24, 2023 Category: Cancer & Oncology Authors: Ya-Ting Huang Tom Wei-Wu Chen Li-Yu Chen Ya-Yao Huang Yen-Shen Lu Source Type: research